Trial Details
COMPLETEDBasic Information
| Clinical ID | c3937 |
|---|---|
| Identifier | NCT01294410 |
| Trial Title | Induction and Maintenance Study of BMS-936557 Patients With Moderate to Severe Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Colitis, Ulcerative |
| Interventions | DRUG: Placebo|DRUG: Placebo|DRUG: Anti-IP-10 Antibody|DRUG: Anti-IP-10 Antibody|DRUG: Anti-IP-10 Antibody|DRUG: Anti-IP-10 Antibody|DRUG: Anti-IP-10 Antibody|DRUG: Anti-IP-10 Antibody |
Participant Information
| Sponsor | Bristol-Myers Squibb |
|---|---|
| City | La Jolla |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2011-03 |
|---|---|
| Primary Completion Date | 2012-12 |
| Completion Date | 2014-12 |